Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2); [Протективный Потенциал Ингибиторов Натрий-Глюкозного Котранспортера 2 Типа В Клинике Внутренних Болезней (Часть 2)]

Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2); [Протективный Потенциал Ингибиторов Натрий-Глюкозного Котранспортера 2 Типа В Клинике Внутренних Болезней (Часть 2)] Publisher

Avagimyan AA¹ ; Sheibani M² ; Trofimenko AI³ ; Lysov EE³ ; Khamidova FM⁴ ; Aznauryan AZ¹ ; Sukiasyan LM¹ ; Sahakyan KT¹ ; Gevorgyan TR¹ ; Tatoyan MR¹ ; Mkrtchyan GL¹ ; Meltonyan GL¹ ; Petrosyan AR¹ ; Martemyanova LA⁵ Show All Authors

Avagimyan AA¹
Sheibani M²
Trofimenko AI³
Lysov EE³
Khamidova FM⁴
Aznauryan AZ¹
Sukiasyan LM¹
Sahakyan KT¹
Gevorgyan TR¹
Tatoyan MR¹
Mkrtchyan GL¹
Meltonyan GL¹
Petrosyan AR¹
Martemyanova LA⁵
Petrosyan RR⁶
Urazova OI⁷
Pogosova NV^{8, 9}
Sarrafzadegan N¹⁰

Show Affiliations

1. Yerevan State Medical University after M. Heratsi, Yerevan, Armenia
2. Iran University of Medical Sciences, Tehran, Iran
3. Kuban State Medical University, Krasnodar, Russian Federation
4. Samarkand State Medical University, Samarkand, Uzbekistan
5. Gomel State Medical University, Gomel, Belarus
6. Lebanese American University, Beirut, Lebanon
7. Siberian State Medical University, Tomsk, Russian Federation
8. National Medical Research Centre of Cardiology after Acad. E.I. Chazov, Moscow, Russian Federation
9. Patrice Lumumba Peoples' Friendship University of Russia, Moscow, Russian Federation
10. Isfahan Cardiovascular Research Centre, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Innovative Medicine of Kuban Published:2025

Abstract

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are now uncovering new possibilities in the field of internal medicine owing to their diverse protective effects. In the second part of the literature review, we explore potential applications of SGLT2i in hepatology, neurology, ophthalmology, and oncology, mechanisms of action of such drugs as dapagliflozin, empagliflozin, canagliflozin, etc, and their effect on different organs and systems. © Ashot A. Avagimyan, Mohammad Sheibani, Artem I. Trofimenko, Evgenii E. Lysov, Farida M. Khamidova, Anahit Z. Aznauryan, Lilit M. Sukiasyan, Karmen T. Sahakyan, Tamara R. Gevorgyan, Marina R. Tatoyan, Gayane L. Mkrtchyan, Goharik L. Meltonyan, Anna R. Petrosyan, Ludmila A. Martemyanova, Ruzanna R. Petrosyan, Olga I. Urazova, Nana V. Pogosova, Nizal Sarrafzadegan.

Related Docs

View other Related Docs

1. Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 1); [Протективный Потенциал Ингибиторов Натрий-Глюкозного Котранспортера 2 Типа В Клинике Внутренних Болезней (Часть 1)], Innovative Medicine of Kuban (2024)

2. Doxorubicin-Induced Cardiometabolic Disturbances: What Can We Do?, Frontiers in Clinical Diabetes and Healthcare (2025)

3. Association Between Sglt2 (Sodium-Glucose Cotransporter-2) Inhibitors and Bladder Cancer in Individuals With Type 2 Diabetes; a Systematic Review and Meta-Analysis, Journal of Nephropathology (2023)

4. Antianginal Effects of Empagliflozin in Patients With Type 2 Diabetes And Refractory Angina; a Randomized, Double-Blind Placebo-Controlled Trial (Empt-Angina Trial), Clinical Cardiology (2024)

5. Comparison of Cardioprotective Effects of Dapagliflozin and Trimetazidine in the Model of Doxorubicin-Cyclophosphamide Cardiotoxicity; [Сравнительная Характеристика Кардиопротекторных Эффектов Дапаглифлозина И Триметазидина На Модели Доксорубицин-Циклофосфамидной Кардиотоксичности], Innovative Medicine of Kuban (2023)

6. Sodium-Glucose Co-Transporter 2 Inhibitors (Sglt2i); As a Preventive Factor of Kidney Failure in Patients With Type 2 Diabetes; a Meta-Analysis of Randomized Controlled Trials, Journal of Renal Injury Prevention (2021)

7. Effect of Sodium–Glucose Cotransporter 2 Inhibitors on Insulin Resistance; a Systematic Review and Meta-Analysis, Acta Diabetologica (2023)

8. Effects of Sodium-Glucose Co-Transporter-2 Inhibitors on Anthropometric Indices and Metabolic Markers in Overweight/Obese Individuals Without Diabetes: A Systematic Review and Meta-Analysis, Current Medical Research and Opinion (2022)

Experts (# of related papers)

View all Related Experts

Nizal Sarrafzadegan (4)

Davood Shafie (1)

Style	Citing Format
MLA	Avagimyan AA, et al.. "Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2); [Протективный Потенциал Ингибиторов Натрий-Глюкозного Котранспортера 2 Типа В Клинике Внутренних Болезней (Часть 2)]." Innovative Medicine of Kuban, vol. 10, no. 1, 2025, pp. 101-109.
APA	Avagimyan AA, Sheibani M, Trofimenko AI, Lysov EE, Khamidova FM, Aznauryan AZ, Sukiasyan LM, Sahakyan KT, Gevorgyan TR, Tatoyan MR, Mkrtchyan GL, Meltonyan GL, Petrosyan AR, Martemyanova LA, Petrosyan RR, Urazova OI, Pogosova NV, Sarrafzadegan N (2025). Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2); [Протективный Потенциал Ингибиторов Натрий-Глюкозного Котранспортера 2 Типа В Клинике Внутренних Болезней (Часть 2)]. Innovative Medicine of Kuban, 10(1), 101-109.
Chicago	Avagimyan AA, Sheibani M, Trofimenko AI, Lysov EE, Khamidova FM, Aznauryan AZ, Sukiasyan LM, et al.. "Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2); [Протективный Потенциал Ингибиторов Натрий-Глюкозного Котранспортера 2 Типа В Клинике Внутренних Болезней (Часть 2)]." Innovative Medicine of Kuban 10, no. 1 (2025): 101-109.
Harvard	Avagimyan AA et al. (2025) 'Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2); [Протективный Потенциал Ингибиторов Натрий-Глюкозного Котранспортера 2 Типа В Клинике Внутренних Болезней (Часть 2)]', Innovative Medicine of Kuban, 10(1), pp. 101-109.
Vancouver	Avagimyan AA, Sheibani M, Trofimenko AI, Lysov EE, Khamidova FM, Aznauryan AZ, et al.. Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2); [Протективный Потенциал Ингибиторов Натрий-Глюкозного Котранспортера 2 Типа В Клинике Внутренних Болезней (Часть 2)]. Innovative Medicine of Kuban. 2025;10(1):101-109.
BibTex	@article{ author = {Avagimyan AA and Sheibani M and Trofimenko AI and Lysov EE and Khamidova FM and Aznauryan AZ and Sukiasyan LM and Sahakyan KT and Gevorgyan TR and Tatoyan MR and Mkrtchyan GL and Meltonyan GL and Petrosyan AR and Martemyanova LA and Petrosyan RR and Urazova OI and Pogosova NV and Sarrafzadegan N}, title = {Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2); [Протективный Потенциал Ингибиторов Натрий-Глюкозного Котранспортера 2 Типа В Клинике Внутренних Болезней (Часть 2)]}, journal = {Innovative Medicine of Kuban}, volume = {10}, number = {1}, pages = {101-109}, year = {2025} }
RIS	TY - JOUR AU - Avagimyan AA AU - Sheibani M AU - Trofimenko AI AU - Lysov EE AU - Khamidova FM AU - Aznauryan AZ AU - Sukiasyan LM AU - Sahakyan KT AU - Gevorgyan TR AU - Tatoyan MR AU - Mkrtchyan GL AU - Meltonyan GL AU - Petrosyan AR AU - Martemyanova LA AU - Petrosyan RR AU - Urazova OI AU - Pogosova NV AU - Sarrafzadegan N TI - Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2); [Протективный Потенциал Ингибиторов Натрий-Глюкозного Котранспортера 2 Типа В Клинике Внутренних Болезней (Часть 2)] JO - Innovative Medicine of Kuban VL - 10 IS - 1 SP - 101 EP - 109 PY - 2025 ER -

Style

Citing Format

MLA

Avagimyan AA, et al.. "Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2); [Протективный Потенциал Ингибиторов Натрий-Глюкозного Котранспортера 2 Типа В Клинике Внутренних Болезней (Часть 2)]." Innovative Medicine of Kuban, vol. 10, no. 1, 2025, pp. 101-109.

APA

Avagimyan AA, Sheibani M, Trofimenko AI, Lysov EE, Khamidova FM, Aznauryan AZ, Sukiasyan LM, Sahakyan KT, Gevorgyan TR, Tatoyan MR, Mkrtchyan GL, Meltonyan GL, Petrosyan AR, Martemyanova LA, Petrosyan RR, Urazova OI, Pogosova NV, Sarrafzadegan N (2025). Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2); [Протективный Потенциал Ингибиторов Натрий-Глюкозного Котранспортера 2 Типа В Клинике Внутренних Болезней (Часть 2)]. Innovative Medicine of Kuban, 10(1), 101-109.

Chicago

Avagimyan AA, Sheibani M, Trofimenko AI, Lysov EE, Khamidova FM, Aznauryan AZ, Sukiasyan LM, et al.. "Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2); [Протективный Потенциал Ингибиторов Натрий-Глюкозного Котранспортера 2 Типа В Клинике Внутренних Болезней (Часть 2)]." Innovative Medicine of Kuban 10, no. 1 (2025): 101-109.

Harvard

Avagimyan AA et al. (2025) 'Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2); [Протективный Потенциал Ингибиторов Натрий-Глюкозного Котранспортера 2 Типа В Клинике Внутренних Болезней (Часть 2)]', Innovative Medicine of Kuban, 10(1), pp. 101-109.

Vancouver

Avagimyan AA, Sheibani M, Trofimenko AI, Lysov EE, Khamidova FM, Aznauryan AZ, et al.. Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2); [Протективный Потенциал Ингибиторов Натрий-Глюкозного Котранспортера 2 Типа В Клинике Внутренних Болезней (Часть 2)]. Innovative Medicine of Kuban. 2025;10(1):101-109.

BibTex

@article{ author = {Avagimyan AA and Sheibani M and Trofimenko AI and Lysov EE and Khamidova FM and Aznauryan AZ and Sukiasyan LM and Sahakyan KT and Gevorgyan TR and Tatoyan MR and Mkrtchyan GL and Meltonyan GL and Petrosyan AR and Martemyanova LA and Petrosyan RR and Urazova OI and Pogosova NV and Sarrafzadegan N}, title = {Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2); [Протективный Потенциал Ингибиторов Натрий-Глюкозного Котранспортера 2 Типа В Клинике Внутренних Болезней (Часть 2)]}, journal = {Innovative Medicine of Kuban}, volume = {10}, number = {1}, pages = {101-109}, year = {2025} }

RIS

TY - JOUR
AU - Avagimyan AA
AU - Sheibani M
AU - Trofimenko AI
AU - Lysov EE
AU - Khamidova FM
AU - Aznauryan AZ
AU - Sukiasyan LM
AU - Sahakyan KT
AU - Gevorgyan TR
AU - Tatoyan MR
AU - Mkrtchyan GL
AU - Meltonyan GL
AU - Petrosyan AR
AU - Martemyanova LA
AU - Petrosyan RR
AU - Urazova OI
AU - Pogosova NV
AU - Sarrafzadegan N
TI - Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2); [Протективный Потенциал Ингибиторов Натрий-Глюкозного Котранспортера 2 Типа В Клинике Внутренних Болезней (Часть 2)]
JO - Innovative Medicine of Kuban
VL - 10
IS - 1
SP - 101
EP - 109
PY - 2025
ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract